TCBP 외환 뉴스
TC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy Innovator
Biotechnology company TC BioPharm (Holdings) plc (TCBP) announced Monday the execution of a non-binding letter of intent to acquire a privately-held biotechnology company pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies for the treatment of refractory cancers and solid tumors.
RTTNews
|
197 일 전
TC BioPharm Unveils Corporate Restructuring Plan; To Cut Up To 30% Of Workforce
Biotechnology company TC BioPharm (Holdings) plc (TCBP) announced Wednesday a corporate restructuring plan to reduce costs and prioritize its pending lead US clinical programs.
RTTNews
|
608 일 전
